A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human ...

CAYMAN ISLANDS - Silexion Therapeutics Corp. (NASDAQ: SLXN), a biotech firm focusing on RNA interference (RNAi) treatments, ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

As hair thinning and skin aging continue to be prevalent concerns worldwide, VCare's latest GFC treatment has emerged as a ...

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy ...

Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently ...

A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.